These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Letter by Mont et al regarding article, "Physical activity and incidence of atrial fibrillation in older adults: the Cardiovascular Health Study". Mont L; Brugada J; Elosua R Circulation; 2009 Feb; 119(5):e195; author reply e196. PubMed ID: 19204312 [No Abstract] [Full Text] [Related]
25. Letter by Kielstein et al regarding article, "High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid". Kielstein JT; Woywodt A; Salpeter SR Circulation; 2007 May; 115(18):e450-1; author reply e451. PubMed ID: 17485587 [No Abstract] [Full Text] [Related]
26. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation. Singer DE; Fang MC; Go AS Arch Intern Med; 2009 Nov; 169(21):2032; author reply 2033. PubMed ID: 19933969 [No Abstract] [Full Text] [Related]
27. Letter regarding article by Mandal et al, "association of anti-heat shock protein 65 antibodies with development of postoperative atrial fibrillation". Auer J; Lamm G; Weber T Circulation; 2005 May; 111(20):e306; author reply e306. PubMed ID: 15911711 [No Abstract] [Full Text] [Related]
28. Sluggish left atria predecessor to stroke in CKD: cause or effect? Saggi SJ; Salifu MO Cardiology; 2013; 124(1):25-7. PubMed ID: 23295387 [No Abstract] [Full Text] [Related]
29. Atrial fibrillation, thromboembolism, and haemostasis: causal or casual associations? Kirchhof P; Schulze-Bahr E Thromb Haemost; 2003 Dec; 90(6):973-5. PubMed ID: 14652625 [No Abstract] [Full Text] [Related]
32. Letter by Sata et Al regarding article,"Plasma brain natriuretic peptide levels indicating thromboembolism in very elderly patients with non-valvular atrial fibrillation". Sata N; Miyahara K; Moriyama Y Circ J; 2008 Jan; 72(1):170; author reply 171. PubMed ID: 18159122 [No Abstract] [Full Text] [Related]
33. Predictors of thromboembolism in atrial fibrillation. Vaziri S; Bikkina M; Levy D Ann Intern Med; 1992 Jul; 117(1):89-90. PubMed ID: 1596053 [No Abstract] [Full Text] [Related]
35. Targeting proteinuria as a valid surrogate for individualized kidney protective therapy. de Zeeuw D Am J Kidney Dis; 2008 May; 51(5):713-6. PubMed ID: 18436079 [No Abstract] [Full Text] [Related]
36. Letter regarding article by Sanders et al, "spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans". Fischer G; Hintringer F Circulation; 2006 Jan; 113(3):e44, author reply e44-5. PubMed ID: 16432061 [No Abstract] [Full Text] [Related]
37. Letter regarding article by Connolly et al, "Challenges of establishing new antithrombotic therapies in atrial fibrillation". Ezekowitz MD; Nagarakanti R Circulation; 2008 Feb; 117(5):e149; author reply e150. PubMed ID: 18250275 [No Abstract] [Full Text] [Related]
38. [Atrial fibrillation and dialysis. A convergence of risk factors]. Grande A Rev Esp Cardiol; 2006 Aug; 59(8):766-9. PubMed ID: 16938224 [No Abstract] [Full Text] [Related]